Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)
Clinical trial NCT01266837 · COMPLETED
Trial details
- NCT number
- NCT01266837
- Sponsor
- iOMEDICO AG
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2017-09-26
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.